Rep. Jodey C. Arrington

Maddy summaryThis bill requires Medicare Advantage plans to implement electronic prior authorization systems by 2027 and publish detailed data on their approval and denial rates for medical services by 2026. It directly affects Medicare Advantage plans (private insurers offering Medicare coverage) and their enrollees (seniors 65+), mandating transparency about prior authorization decisions, processing times, and appeal outcomes. Key provisions include requiring plans to report annual statistics on request approvals/denials, average processing times, and use of technology, with this data published publicly by the Centers for Medicare & Medicaid Services. The bill also sets timelines for plan responses to prior authorization requests and mandates reports to Congress on implementation and impacts.

Maddy summary# Summary of Tariff Suspensions and Reductions Document This document is a section of U.S. tariff legislation that adds new duty suspensions and reductions to the Harmonized Tariff Schedule of the United States. It contains 120 new tariff items (numbered 9902.19.01 through 9902.20.24) that provide temporary duty-free or reduced-duty status for various goods. Key features of the document: 1. **Content**: The list includes chemical compounds, food ingredients, and specialty materials (such as shelled pine nuts, licorice extract, refined carrageenan, various chemicals like neodymium metal, tungsten concentrate, and numerous organic compounds). 2. **Tariff Treatment**: Most entries are listed as "Free" (meaning duty-free), with a few having small duty rates (e.g., 0.7%, 1.8%, 2.3%, 2.9%, 4.3%). 3. **Effective Period**: All listed suspensions and reductions are effective "On or before 12/31/2025." 4. **Purpose**: These tariff suspensions are intended to support specific industries, reduce costs for manufacturers, or provide temporary relief for certain imported goods. 5. **Technical Details**: Each entry includes the chemical name, CAS number, Harmonized Tariff Schedule code, duty rate, and a brief description of the product. This document represents a legislative amendment to the Harmonized Tariff Schedule, specifically adding new subchapter II of chapter 99 to provide temporary duty relief for these specific items.

Maddy summary# Summary of Proposed Legislation This document outlines a comprehensive U.S. legislative proposal with several key components: 1. **Research Restrictions**: - Requires certification from Federal research grant recipients that they are not Chinese citizens or participants in Chinese talent programs - Prohibits employment of Chinese nationals in federally funded research - Requires institutions receiving Federal assistance to agree not to knowingly employ individuals participating in Chinese talent programs 2. **Foreign Gifts and Contracts Disclosure**: - Mandates disclosure of foreign gifts/contracts over $50,000 to universities - Requires public reporting of restricted/conditional gifts/contracts - Creates a searchable public database of foreign gifts to universities - Requires institutions to maintain policies regarding foreign gifts to faculty and staff 3. **Investment Restrictions**: - Restricts tax-exempt organizations from holding investments in "disqualified Chinese companies" (defined as corporations incorporated in China or with significant Chinese government ownership) - Requires annual reporting on such investments - Allows limited waivers with public disclosure 4. **Taiwan Policy**: - Prohibits U.S. government from recognizing PRC claims to sovereignty over Taiwan without Taiwan's consent - Requires U.S. government to treat Taiwan's democratically elected government as the legitimate representative of the people of Taiwan - Requires a strategy to protect U.S. businesses from Chinese coercion efforts 5. **Additional Provisions**: - Requires participants in Chinese talent programs to register as agents of the Chinese government - Amends economic espionage laws to include education and research - Mandates disclosure of certain funds received by visa holders The legislation represents a significant effort to limit Chinese influence in U.S. academic institutions, research, and business sectors while establishing a more robust policy framework regarding Taiwan.

Maddy summaryHR 7431 requires states administering Temporary Assistance for Needy Families (TANF) cash assistance programs to apply federal payment integrity rules (from the 2019 Payment Integrity Information Act) to their TANF programs starting October 1, 2025. It mandates a report to Congress within one year of enactment detailing a 10-year plan to reduce improper payments in state TANF programs. The bill also extends TANF funding through September 30, 2026, at 2023 fiscal year levels without new appropriations. This directly affects state welfare agencies and the low-income families receiving TANF cash assistance.

Maddy summaryThe Maximum Pressure Act (HR 6114) is a legislative proposal that would maintain and expand U.S. sanctions against Iran. The bill would codify existing sanctions, require Iran to meet 12 specific conditions before sanctions could be lifted (including ending support for terrorism, releasing hostages, and ending nuclear enrichment), and expand sanctions on Iran's Revolutionary Guard Corps and missile programs. It also establishes new reporting requirements for the U.S. government to monitor Iran's activities and the impact of sanctions. The legislation would require congressional review before any sanctions could be lifted or modified, preventing the executive branch from unilaterally easing restrictions.

Maddy summaryThe DRA of 2023 adjusts Medicare payment rates for specific durable medical equipment (DME) items that were part of the 2021 competitive bidding program but for which no supplier contracts were finalized. It directly affects DME suppliers and Medicare beneficiaries by establishing a new 2024 payment formula: 90% of the adjusted payment amount plus 10% of the unadjusted fee schedule for eligible items. The bill also extends a temporary transition rule for non-rural areas through December 31, 2024, while delaying a regulatory change until 2025. These provisions aim to stabilize payments for DME items that did not transition to standard pricing under prior rules.

Maddy summaryThis bill requires group health plans and health insurance issuers to submit detailed annual reports to plan sponsors about prescription drug spending, including gross costs, rebates received, out-of-pocket expenses by participants, and information about formulary placement for high-cost drugs. The reports must include specific data points like drug names, costs per unit, and details about prescription patterns across different dispensing channels. The bill prohibits contracts that limit disclosure of information related to pharmacy benefits management services and establishes civil penalties of up to $10,000 per day for non-compliance. The reporting requirements will take effect for plan years beginning 3 years after enactment, with reports submitted in machine-readable format to the Comptroller General for a GAO study on pharmacy networks.

Maddy summaryHR 4473, the Medicare Patient Access to Cancer Treatment Act, requires Medicare to pay the same rate for cancer care services whether provided in a hospital outpatient department or a physician’s office. It directly affects Medicare beneficiaries receiving cancer treatment and healthcare providers (hospitals and physician offices) who deliver cancer care services. The bill mandates equal reimbursement for defined cancer care services - such as chemotherapy administration and cancer diagnosis/treatment - starting in 2025, eliminating current higher payments for hospital settings. This change aims to reduce unnecessary cost increases for Medicare (estimated $615 million added between 2015-2019 due to current payment disparities) without altering care quality.

Maddy summaryThis bill prohibits federal funding for gender transition procedures - including hormone therapy, puberty blockers, and surgeries like genital reassignment - across all federal programs and health plans. It exempts procedures for medical conditions (such as disorders of sex development) and treatment of complications arising from such procedures. The bill also blocks Affordable Care Act premium tax credits and cost-sharing reductions for health plans covering these services, though individuals may purchase separate non-federal-funded coverage. State and private insurers can still offer such coverage using their own funds, but federal subsidies cannot be applied to it.

Maddy summaryHR 3129, the Health Care Fairness for All Act, repeals the individual and employer health insurance mandates established under the Affordable Care Act. The bill provides states with increased flexibility to regulate health insurance outside of health insurance exchanges while maintaining certain consumer protections like coverage for pre-existing conditions and dependent coverage through age 26. It introduces a new health insurance tax credit to help individuals afford coverage and changes Health Savings Accounts (HSAs) to be non-deductible. The bill also includes Medicare reforms such as promoting site-neutral payments and extending acute hospital care at home programs.